Nav: Home

Computational method makes gene expression analyses more accurate

March 06, 2017

PITTSBURGH--A new computational method can improve the accuracy of gene expression analyses, which are increasingly used to diagnose and monitor cancers and are a major tool for basic biological research.

Researchers from Carnegie Mellon University, Stony Brook University and Dana-Farber Cancer Institute said their method, called Salmon, is able to correct for the technical biases that are known to occur during RNA sequencing, or RNA-seq, the leading method for estimating gene expression. Furthermore, it operates at similar speeds as other fast methods - a critical factor as these tests are growing more common and numerous.

Their report is being published online March 6 by the journal Nature Methods. Carl Kingsford, associate professor in CMU's Computational Biology Department, said the Salmon source code is freely available online and already has been downloaded by thousands of users.

"Salmon provides a much richer model of the RNA-seq experiment and of the possible biases that are known to occur during sequencing," Kingsford said. This is important, he added, because this technique is increasingly used for classifying diseases and their subtypes, understanding gene expression changes during development and tracking the progression of cancer.

Though an organism's genetic makeup is static, the activity of individual genes varies greatly over time, making gene expression an important factor in understanding how organisms work and what occurs during disease processes. Gene activity can't be efficiently measured directly, but can be inferred by monitoring RNA, the molecules that carry information from the genes for producing proteins and other cellular activities.

RNA-seq is a leading technology for producing these snapshots of gene activity. But depending on the tissue being analyzed and the way each sample is prepared, various experimental biases can occur and cause RNA-seq "reads" to be over- or under-sampled from various genes, Kingsford said.

"Though we know many of the kinds of biases that can occur, modeling them has to occur on a sample-by-sample basis," he added. "And if you have to build a complicated bias model using traditional methods, it takes a really long time."

The researchers named the method after a fish famous for swimming upstream because it employs an algorithm that can estimate the effect of biases and the expression level of genes as experimental data streams by.

"In that way, it is able to build up a rich bias model and do so approximately as fast as other fast analysis tools," Kingsford said.
-end-
The research was led by Kingsford and Rob Patro, assistant professor of computer science at Stony Brook. The research team also included Geet Duggal of DNANexus, who worked on this project as a post-doctoral researcher at CMU, and Michael I. Love and Rafael A. Irizarry, biostatisticians at Dana Farber and the Harvard T.H. Chan School of Public Health. Love has since joined the University of North Carolina-Chapel Hill as an assistant professor of biostatistics.

The Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative, the National Science Foundation and the National Institutes of Health supported this research.

About Carnegie Mellon University: Carnegie Mellon is a private, internationally ranked research university with programs in areas ranging from science, technology and business, to public policy, the humanities and the arts. More than 13,000 students in the university's seven schools and colleges benefit from a small student-to-faculty ratio and an education characterized by its focus on creating and implementing solutions for real problems, interdisciplinary collaboration and innovation.

Carnegie Mellon University

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...